Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?

The reason why dopamine neurons die in Parkinson’s disease remains largely unknown. Emerging evidence points to a role for brain inflammation in neurodegeneration. Essential questions are whether brain inflammation happens sufficiently early so that interfering with this process can be expected to s...

Full description

Bibliographic Details
Main Author:	Vidar Gundersen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Neuroscience
Subjects:	microglia alpha-synuclein T-cells brain gut cervical lymph node
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2020.580311/full

Similar Items

Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
by: Elzbieta Janda, et al.
Published: (2018-04-01)

Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
by: Thuy Thi Lai, et al.
Published: (2021-10-01)

Gut and Parkinson’s disease
by: Sujith Ovallath, et al.
Published: (2018-01-01)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
by: Emily Fitzgerald, et al.
Published: (2019-04-01)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
by: Johan Wallin, et al.
Published: (2021-05-01)

Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease
by: Alice Drobny, et al.
Published: (2021-07-01)

Neuroprotective Treatments in Parkinson’s Disease
by: Elif, et al.
Published: (2019-12-01)

Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease?
by: Junichi Matsumoto, et al.
Published: (2017-09-01)

Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
by: Alix Booms, et al.
Published: (2021-10-01)

Microbiome, Parkinson’s Disease and Molecular Mimicry
by: Fabiana Miraglia, et al.
Published: (2019-03-01)

NADPH oxidases in Parkinson’s disease: a systematic review
by: Karim Belarbi, et al.
Published: (2017-11-01)

Can ultrasound elastography distinguish metastatic from reactive lymph nodes in patients with primary head and neck cancers?
by: Mohamed Mohamed Hefeda, et al.
Published: (2014-09-01)

A Novel Microfluidic Cell Co-Culture Platform for the Study of the Molecular Mechanisms of Parkinson’s Disease and other Synucleinopathies
by: João Tiago Fernandes, et al.
Published: (2016-11-01)

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
by: Sonia George, et al.
Published: (2019-08-01)

Alpha Synuclein Connects the Gut-Brain Axis in Parkinson’s Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology
by: Eva Schaeffer, et al.
Published: (2020-09-01)

Radiomic models for lymph node metastasis prediction in cervical cancer: can we think beyond sentinel lymph node?
by: Nicolò Bizzarri, et al.
Published: (2021-10-01)

Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2
by: Yae Ji Choi, et al.
Published: (2021-01-01)

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
by: Bipul Ray, et al.
Published: (2021-05-01)

Analysis of risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma: a study of 268 patients
by: Jian-hua Gu, et al.
Published: (2019-11-01)

Inflammation, Infectious Triggers, and Parkinson's Disease
by: Elisa Caggiu, et al.
Published: (2019-02-01)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01)

Mechanisms of Neurodegeneration and Neuroprotection in Parkinson’s and Alzheimer's Disease
by: Ismael, Sazan Khalid
Published: (2019)

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
by: Alexia Polissidis, et al.
Published: (2020-06-01)

Desulfovibrio Bacteria Are Associated With Parkinson’s Disease
by: Kari E. Murros, et al.
Published: (2021-05-01)

Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
by: Dominika Fricova, et al.
Published: (2020-11-01)

Parkinson's disease and a dopamine-derived neurotoxin, 3,4-Dihydroxyphenylacetaldehyde : implications for proteins, microglia, and neurons
by: Eckert, Laurie Leigh
Published: (2012)

Autoimmune antibody decline in Parkinson’s disease and Multiple System Atrophy; a step towards immunotherapeutic strategies
by: Tomasz Brudek, et al.
Published: (2017-06-01)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01)

Détection et caractérisation de l'α-synucléine dans le système nerveux entérique en conditions physiologiques et dans la maladie de Parkinson
by: Corbillé, Anne-Gaëlle
Published: (2016)

Microglial inclusions and neurofilament light chain release follow neuronal α-synuclein lesions in long-term brain slice cultures
by: Melanie Barth, et al.
Published: (2021-08-01)

Dysfunctional mitochondria uphold calpain activation: Contribution to Parkinson's disease pathology
by: A. Raquel Esteves, et al.
Published: (2010-03-01)

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics
by: Cristoforo Comi, et al.
Published: (2019-10-01)

Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial
by: Guillaume Favre, et al.
Published: (2021-02-01)

An Introspective Approach: A Lifetime of Parkinson’s Disease Research and Not Much to Show for it Yet?
by: Gordon W. Arbuthnott
Published: (2021-02-01)

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
by: Yuanyuan Li, et al.
Published: (2019-12-01)

Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients
by: Chen Ying, et al.
Published: (2013-02-01)

Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity
by: Dafina M. Angelova, et al.
Published: (2018-08-01)

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
by: Qian-Qian Chen, et al.
Published: (2019-09-01)

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
by: Yunna Li, et al.
Published: (2021-10-01)

Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson’s disease
by: Ya-Nan Zhang, et al.
Published: (2021-01-01)